Antisense modulation of apolipoprotein B expression
Details for Australian Patent Application No. 2003294281 (hide)
International Classifications
Event Publications
22 April 2004 Complete Application Filed
Priority application(s): PCT/US03/15493 15.05.03 US; 60/426,234 13.11.02 US
8 July 2004 Application Open to Public Inspection
Published as AU-B-2003294281
20 May 2010 Assignment before Grant
Isis Pharmaceuticals, Inc. The application has been assigned to Genzyme Corporation 2005
20 May 2010 Application Accepted
Published as AU-B-2003294281
16 September 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser